Mangoceuticals Inc
NASDAQ:MGRX
Intrinsic Value
Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. [ Read More ]
The intrinsic value of one MGRX stock under the Base Case scenario is 0.0251 USD. Compared to the current market price of 0.2631 USD, Mangoceuticals Inc is Overvalued by 90%.
Valuation Backtest
Mangoceuticals Inc
Run backtest to discover the historical profit from buying and selling MGRX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Mangoceuticals Inc
Current Assets | 818.5k |
Cash & Short-Term Investments | 739k |
Other Current Assets | 79.5k |
Non-Current Assets | 232.3k |
PP&E | 215.4k |
Other Non-Current Assets | 16.9k |
Current Liabilities | 211.1k |
Accounts Payable | 140.8k |
Accrued Liabilities | 70.3k |
Non-Current Liabilities | 65k |
Other Non-Current Liabilities | 65k |
Earnings Waterfall
Mangoceuticals Inc
Revenue
|
731.5k
USD
|
Cost of Revenue
|
-300k
USD
|
Gross Profit
|
431.5k
USD
|
Operating Expenses
|
-9.7m
USD
|
Operating Income
|
-9.2m
USD
|
Other Expenses
|
6.5k
USD
|
Net Income
|
-9.2m
USD
|
Free Cash Flow Analysis
Mangoceuticals Inc
MGRX Profitability Score
Profitability Due Diligence
Mangoceuticals Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Mangoceuticals Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
MGRX Solvency Score
Solvency Due Diligence
Mangoceuticals Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Mangoceuticals Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MGRX Price Targets Summary
Mangoceuticals Inc
Ownership
MGRX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
MGRX Price
Mangoceuticals Inc
Average Annual Return |
N/A
|
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -96% |
Market Capitalization | 6.5m USD |
Shares Outstanding | 24 619 500 |
Percentage of Shares Shorted | 5.25% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.
Contact
IPO
Employees
Officers
The intrinsic value of one MGRX stock under the Base Case scenario is 0.0251 USD.
Compared to the current market price of 0.2631 USD, Mangoceuticals Inc is Overvalued by 90%.